Patents by Inventor Peter Herrmann

Peter Herrmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250135107
    Abstract: Embodiments provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: January 3, 2025
    Publication date: May 1, 2025
    Applicant: Rani Therapeutics, LLC
    Inventors: Mir IMRAN, Peter HERRMANN, Baber SYED, Timothy H. WILLIAMS, Chang Jin ONG, Greg METHOD
  • Patent number: 12263325
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Grant
    Filed: October 5, 2023
    Date of Patent: April 1, 2025
    Assignee: Rani Therapeutics, LLC
    Inventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Publication number: 20240082488
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: October 5, 2023
    Publication date: March 14, 2024
    Applicant: Rani Therapeutics, LLC
    Inventors: Mir IMRAN, Peter HERRMANN, Baber SYED, Timothy H. WILLIAMS, Chang Jin ONG, Greg METHOD
  • Patent number: 11806504
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: November 7, 2023
    Assignee: RANI THERAPEUTICS, LLC
    Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Patent number: 11579010
    Abstract: A load cell includes a bearing element configured for a hoist that includes a hook, a suspension with an orifice that receives a shaft of the hook, a nut, and housing. The bearing element, preferably a ring, contacts the suspension, and has an orifice that receives the shaft therethrough with the nut secured to the shaft proximate to the bearing element. Strain gauges are mounted on the ring side wall being equally spaced. A second suspension orifice concentric with the first orifice receives the ring with strain gauges therein. For improved accuracy, a thrust roller bearing and two thrust washers are positioned on sides of the ring, all of which are preferably positioned in a cup member that is received in the second orifice. A clearance fit is provided with respect to each of protruding upper and lower overhanging cylindrical ring lips and the cup to protect the gauges.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: February 14, 2023
    Assignee: Motion Laboratories, Inc.
    Inventors: Peter Herrmann, Philip Nubile
  • Patent number: 11182601
    Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: November 23, 2021
    Assignee: DEERE & COMPANY
    Inventors: Christoph Wagner, Peter Herrmann
  • Publication number: 20200311399
    Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.
    Type: Application
    Filed: March 12, 2020
    Publication date: October 1, 2020
    Inventors: CHRISTOPH WAGNER, PETER HERRMANN
  • Publication number: 20200289747
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: March 24, 2020
    Publication date: September 17, 2020
    Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Patent number: 10632251
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: April 28, 2020
    Assignee: Rani Therapeutics, LLC
    Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Publication number: 20180008771
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: August 10, 2017
    Publication date: January 11, 2018
    Applicant: Rani Therapeutics, LLC
    Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Patent number: 9757514
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: September 12, 2017
    Assignee: Rani Therapeutics, LLC
    Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Publication number: 20140221927
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: April 3, 2014
    Publication date: August 7, 2014
    Applicant: Rani Therapeutics, LLC
    Inventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Patent number: 8734429
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: May 27, 2014
    Assignee: Rani Therapeutics, LLC
    Inventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Publication number: 20130274659
    Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Applicant: InCube Labs, LLC
    Inventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
  • Patent number: 7442873
    Abstract: An improved enclosure for electrical components is provided. The enclosure protects components from the environment. The enclosure may rest on a surface and to move it from one location to another the enclosure may be rotated 90° and can travel on top and bottom side wall portions. There is a recessed portion between the top and bottom side wall portion where electrical connections may be present and do not interfere with movement of the enclosure.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: October 28, 2008
    Inventors: Sean McCormick, Peter Herrmann, William Froehlich
  • Publication number: 20070210087
    Abstract: An improved enclosure for electrical components is provided. The enclosure protects components from the environment. The enclosure may rest on a surface and to move it from one location to another the enclosure may be rotated 90° and can travel on top and bottom side wall portions. There is a recessed portion between the top and bottom side wall portion where electrical connections may be present and do not interfere with movement of the enclosure.
    Type: Application
    Filed: February 3, 2006
    Publication date: September 13, 2007
    Inventors: Sean McCormick, Peter Herrmann, William Froehlich
  • Patent number: 6909966
    Abstract: A navigational device in which a position is storable by actuating a control element and this position may be input as a driving destination by re-actuating the control element. This simplifies the input of an often frequented driving destination such as a place of residence.
    Type: Grant
    Filed: July 4, 2002
    Date of Patent: June 21, 2005
    Assignee: Robert Bosch GmbH
    Inventors: Walter Schaefer, Peter Herrmann
  • Publication number: 20040054466
    Abstract: A navigational device is described where a position is storable by actuating a control element and this position may be input as a driving destination by re-actuating the control element. This simplifies the input of an often frequented driving destination, e.g., the place of residence.
    Type: Application
    Filed: September 25, 2003
    Publication date: March 18, 2004
    Inventors: Walter Schaefer, Peter Herrmann
  • Patent number: 6316236
    Abstract: A method is provided for preparing a highly purified lysozyme dimer product which comprises dimerizing the lysozyme monomer with a suberimidate coupling reagent in a buffer solution adjusted to pH 10, stopping the dimerization at a given point by lowering the pH to 7 via addition of HCl or other suitable acid solution, and purifying the dimeric lysozyme by a series of elution steps carried out using ion exchange resin column chromatography. Monomeric lysozyme remaining undimerized by the initial dimerization step is recycled into the process in order to increase yield. The present system is advantageous in that large amounts of purified lysozyme dimer can be prepared efficiently and relatively inexpensively, and the lysozyme dimer so produced is useful in treating viral and/or bacterial diseases without causing the cytotoxic effects associated with the lysozyme monomer.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: November 13, 2001
    Assignee: Nika Health Products Limited
    Inventors: Peter Herrmann, Peter Klein
  • Patent number: 6040167
    Abstract: The phospholipid bilayer contains at least one pharmaceutically active drug and comprises cell-specific markers on the membrane which have at least 90% biological activity when measured according to Luescher & Glueck, Antiviral Research 14, 39-50. In the membrane, the cholesterol content is preferably less than 2% by weight, the detergent content preferably less than 1 ppb. The vesicle diameter preferably is about 80 nm. the phospholipid in the membrane may comprise 70 to 95% by weight of phosphatidylcholine and preferably 10 to 20% by weight of phosphatidylethanolamine; preferably 6-8% by weight of a crosslinker, preferably of a sulfosuccinimidyl derivate, and at least one cell-specific fusion peptide are linked to the membrane. The vesicles are used for the preparation of pharmaceuticals against AIDS and carcinomas.
    Type: Grant
    Filed: November 2, 1992
    Date of Patent: March 21, 2000
    Assignee: Nika Health Products Limited
    Inventors: Reinhard Gluck, Peter Klein, Peter Herrmann, Ernst Rudolf Walti